{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:11:06Z","timestamp":1788977466238,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03495-3","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:50:06Z","timestamp":1788976206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-emulsifying Delivery System for Improving Biopharmaceutical Performance of a Novel Antitubercular Agent: Formulation Development, Biological Activity and Pharmacokinetic Evaluation"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9164-8085","authenticated-orcid":false,"given":"Gourav","family":"Paudwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8487-3109","authenticated-orcid":false,"given":"Rigzin","family":"Dolkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1234-7832","authenticated-orcid":false,"given":"Anjali","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7651-8071","authenticated-orcid":false,"given":"Mahir","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0686-7126","authenticated-orcid":false,"given":"Rashmi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8824-7945","authenticated-orcid":false,"given":"Parvinder Pal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3072-7000","authenticated-orcid":false,"given":"Prem N.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"6","key":"3495_CR1","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/jam.14478","volume":"128","author":"R Singh","year":"2020","unstructured":"Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2020;128(6):1547\u201367.","journal-title":"J Appl Microbiol"},{"issue":"4","key":"3495_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.12701\/yujm.2020.00626","volume":"37","author":"JG Jang","year":"2020","unstructured":"Jang JG, Chung JH. Diagnosis and treatment of multidrug-resistant tuberculosis. Yeungnam Univ J Med. 2020;37(4):277\u201385.","journal-title":"Yeungnam Univ J Med"},{"key":"3495_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.coph.2021.05.007","volume":"59","author":"M Mondoni","year":"2021","unstructured":"Mondoni M, Saderi L, Sotgiu G. Novel treatments in multidrug-resistant tuberculosis. Curr Opin Pharmacol. 2021;59:103\u201315.","journal-title":"Curr Opin Pharmacol"},{"key":"3495_CR4","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1021\/acsmedchemlett.5b00202","volume":"6","author":"KR Yempalla","year":"2015","unstructured":"Yempalla KR, Munagala G, Singh S, Kour G, Sharma S, Chib R, et al. ACS Med Chem Lett. 2015;6:1059\u201364.","journal-title":"ACS Med Chem Lett"},{"issue":"3","key":"3495_CR5","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00922-w","volume":"26","author":"G Paudwal","year":"2024","unstructured":"Paudwal G, Dolkar R, Perveen S, Sharma R, Singh PP, Gupta PN. Third generation solid dispersion-based formulation of novel anti-tubercular agent exhibited improvement in solubility, dissolution and biological activity. AAPS J. 2024;26(3):52.","journal-title":"AAPS J"},{"issue":"10","key":"3495_CR6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/jps.2600821008","volume":"82","author":"BJ Aungst","year":"1993","unstructured":"Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci. 1993;82(10):979\u201387.","journal-title":"J Pharm Sci"},{"issue":"2","key":"3495_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0378-5173(00)00614-1","volume":"212","author":"TR Kommuru","year":"2001","unstructured":"Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001;212(2):233\u201346.","journal-title":"Int J Pharm"},{"key":"3495_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/B978-0-12-814029-1.00002-8","volume-title":"Applications of targeted nano drugs and delivery systems","author":"AK Goyal","year":"2019","unstructured":"Goyal AK, Rath G, Faujdar C, Malik B. Application and perspective of pH-responsive nano drug delivery systems. In: Applications of targeted nano drugs and delivery systems. Elsevier; 2019. p. 15\u201333."},{"issue":"3","key":"3495_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1096\/fj.04-2747rev","volume":"19","author":"SM Moghimi","year":"2005","unstructured":"Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J. 2005;19(3):311\u201330.","journal-title":"FASEB J"},{"issue":"11","key":"3495_CR10","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1517\/17425247.2011.614228","volume":"8","author":"P van Hoogevest","year":"2011","unstructured":"van Hoogevest P, Liu X, Fahr A. Drug delivery strategies for poorly water-soluble drugs: the industrial perspective. Expert Opin Drug Deliv. 2011;8(11):1481\u2013500.","journal-title":"Expert Opin Drug Deliv"},{"key":"3495_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-3-031-14100-3_14","volume-title":"Tubercular drug delivery systems: advances in treatment of infectious diseases","author":"S Alom","year":"2023","unstructured":"Alom S, Ali F, Choudhury D, Gohain A, Ahmed AB, Zaman MK. Tuberculosis and drug delivery system: clinical trials in TB. In: Tubercular drug delivery systems: advances in treatment of infectious diseases. 2023. p. 289\u2013305."},{"issue":"1-2","key":"3495_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijpharm.2003.12.028","volume":"274","author":"BK Kang","year":"2004","unstructured":"Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004;274(1\u20132):65\u201373.","journal-title":"Int J Pharm"},{"issue":"3","key":"3495_CR13","doi-asserted-by":"publisher","first-page":"E344","DOI":"10.1208\/aapsj0903041","volume":"9","author":"AR Patel","year":"2007","unstructured":"Patel AR, Vavia PR. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J. 2007;9(3):E344\u201352.","journal-title":"AAPS J"},{"issue":"1-2","key":"3495_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijpharm.2006.08.038","volume":"329","author":"AA Date","year":"2007","unstructured":"Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2007;329(1\u20132):166\u201372.","journal-title":"Int J Pharm"},{"issue":"1","key":"3495_CR15","first-page":"93","volume":"12","author":"S Mehrandish","year":"2022","unstructured":"Mehrandish S, Mirzaeei S. Design of novel nanoemulsion formulations for topical ocular delivery of itraconazole: development, characterization and in vitro bioassay. Adv Pharm Bull. 2022;12(1):93\u2013101.","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"3495_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejpb.2011.01.025","volume":"79","author":"G Shahnaz","year":"2011","unstructured":"Shahnaz G, Hartl M, Barthelmes J, Leithner K, Sarti F, Hintzen F, et al. Uptake of phenothiazines by the harvested chylomicrons ex vivo model: influence of self-nanoemulsifying formulation design. Eur J Pharm Biopharm. 2011;79(1):171\u201380.","journal-title":"Eur J Pharm Biopharm"},{"key":"3495_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106159","volume":"174","author":"DY Usta","year":"2022","unstructured":"Usta DY, Timur B, Teksin ZS. Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: a novel alternative dosage form for pulmonary arterial hypertension treatment. Eur J Pharm Sci. 2022;174:106159.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"3495_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics8030020","volume":"8","author":"A Nasr","year":"2016","unstructured":"Nasr A, Gardouh A, Ghorab M. Novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of Olmesartan Medoxomil: design, formulation, pharmacokinetic and bioavailability evaluation. Pharmaceutics. 2016;8(3):20.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3495_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s43094-022-00434-4","volume":"8","author":"MR Reddy","year":"2022","unstructured":"Reddy MR, Gubbiyappa KS. Formulation development, optimization and characterization of Pemigatinib-loaded supersaturable self-nanoemulsifying drug delivery systems. Futur J Pharm Sci. 2022;8(1):45.","journal-title":"Futur J Pharm Sci"},{"key":"3495_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejpb.2019.09.007","volume":"144","author":"I Nazir","year":"2019","unstructured":"Nazir I, F\u00fcrst A, Lupo N, Hupfauf A, Gust R, Bernkop-Schn\u00fcrch A. Zeta potential changing self-emulsifying drug delivery systems: A promising strategy to sequentially overcome mucus and epithelial barrier. Eur J Pharm Biopharm. 2019;144:40\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"3495_CR21","volume":"2013","author":"ST Prajapati","year":"2013","unstructured":"Prajapati ST, Joshi HA, Patel CN. Preparation and Characterization of Self-Microemulsifying Drug Delivery System of Olmesartan Medoxomil for Bioavailability Improvement. J Pharm (Cairo). 2013;2013:728425.","journal-title":"J Pharm (Cairo)"},{"issue":"1","key":"3495_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1208\/s12249-009-9347-6","volume":"11","author":"V Nekkanti","year":"2010","unstructured":"Nekkanti V, Karatgi P, Prabhu R, Pillai R. Solid self-microemulsifying formulation for candesartan cilexetil. AAPS PharmSciTech. 2010;11(1):9\u201317.","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"3495_CR23","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-01765-2","volume":"21","author":"C Karavasili","year":"2020","unstructured":"Karavasili C, Andreadis II, Tsantarliotou MP, Taitzoglou IA, Chatzopoulou P, Katsantonis D, et al. Self-nanoemulsifying drug delivery systems (SNEDDS) containing rice bran oil for enhanced fenofibrate oral delivery: in vitro digestion, ex vivo permeability, and in vivo bioavailability studies. AAPS PharmSciTech. 2020;21(6):208.","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"3495_CR24","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1007\/s11095-013-1106-4","volume":"30","author":"SG Gumaste","year":"2013","unstructured":"Gumaste SG, Dalrymple DM, Serajuddin AT. Development of solid SEDDS, V: compaction and drug release properties of tablets prepared by adsorbing lipid-based formulations onto Neusilin\u00ae US2. Pharm Res. 2013;30(12):3186\u201399.","journal-title":"Pharm Res"},{"issue":"4","key":"3495_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11095-017-2327-8","volume":"35","author":"J Keemink","year":"2018","unstructured":"Keemink J, Bergstr\u00f6m CAS. Caco-2 cell conditions enabling studies of drug absorption from digestible lipid-based formulations. Pharm Res. 2018;35(4):74.","journal-title":"Pharm Res"},{"key":"3495_CR26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ejps.2016.12.018","volume":"99","author":"P Bu","year":"2017","unstructured":"Bu P, Ji Y, Narayanan S, Dalrymple D, Cheng X, Serajuddin AT. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant. Eur J Pharm Sci. 2017;99:350\u201360.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"3495_CR27","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1208\/s12249-018-1080-6","volume":"19","author":"M Lavan","year":"2018","unstructured":"Lavan M, Knipp G. Effects of dendrimer-like biopolymers on physical stability of amorphous solid dispersions and drug permeability across Caco-2 cell monolayers. AAPS PharmSciTech. 2018;19(6):2459\u201371.","journal-title":"AAPS PharmSciTech"},{"key":"3495_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.freeradbiomed.2013.05.041","volume":"65","author":"S Jain","year":"2013","unstructured":"Jain S, Jain AK, Pohekar M, Thanki K. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity. Free Radic Biol Med. 2013;65:117\u201330.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"3495_CR29","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-01855-1","volume":"21","author":"JG Meher","year":"2020","unstructured":"Meher JG, Dixit S, Singh Y, Pawar VK, Konwar R, Saklani R, et al. Paclitaxel-loaded colloidal silica and TPGS-based solid self-emulsifying system interferes Akt\/MTOR pathway in MDA-MB-231 and demonstrates anti-tumor effect in syngeneic mammary tumors. AAPS PharmSciTech. 2020;21(8):313.","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"3495_CR30","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","volume":"46","author":"JC Palomino","year":"2002","unstructured":"Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2002;46(8):2720\u20132.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3495_CR31","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1128\/AAC.00260-15","volume":"59","author":"RV Swanson","year":"2015","unstructured":"Swanson RV, Adamson J, Moodley C, Ngcobo B, Ammerman NC, Dorasamy A, et al. Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis. Antimicrob Agents Chemother. 2015;59(6):3042\u201351.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3\u20134","key":"3495_CR32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","volume":"29","author":"CW Pouton","year":"2006","unstructured":"Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29(3\u20134):278\u201387.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3495_CR33","first-page":"35","volume":"15","author":"MS Alam","year":"2016","unstructured":"Alam MS, Ali MS, Zakir F, Alam N, Alam MI, Ahmad F, et al. Enhancement of Anti-Dermatitis Potential of Clobetasol Propionate by DHA [Docosahexaenoic Acid] Rich Algal Oil Nanoemulsion Gel. Iran J Pharm Res. 2016;15(1):35\u201352.","journal-title":"Iran J Pharm Res"},{"issue":"1","key":"3495_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ijpharm.2016.06.045","volume":"510","author":"W Suchaoin","year":"2016","unstructured":"Suchaoin W, Pereira de Sousa I, Netsomboon K, Lam HT, Laffleur F, Bernkop-Schn\u00fcrch A. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation. Int J Pharm. 2016;510(1):255\u201362.","journal-title":"Int J Pharm"},{"issue":"6","key":"3495_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.addr.2007.10.010","volume":"60","author":"CW Pouton","year":"2008","unstructured":"Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60(6):625\u201337.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3495_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/jfb5020043","volume":"5","author":"J L\u00f3pez-Garc\u00eda","year":"2014","unstructured":"L\u00f3pez-Garc\u00eda J, Lehock\u00fd M, Humpol\u00ed\u010dek P, S\u00e1ha P. HaCaT Keratinocytes Response on Antimicrobial Atelocollagen Substrates: Extent of Cytotoxicity, Cell Viability and Proliferation. J Funct Biomater. 2014;5(2):43\u201357.","journal-title":"J Funct Biomater"},{"issue":"3","key":"3495_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.biopha.2004.02.001","volume":"58","author":"RN Gursoy","year":"2004","unstructured":"Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58(3):173\u201382.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"3495_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.addr.2007.10.014","volume":"60","author":"CJ Porter","year":"2008","unstructured":"Porter CJ, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60(6):673\u201391.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"3495_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.addr.2007.10.012","volume":"60","author":"CM O'Driscoll","year":"2008","unstructured":"O\u2019Driscoll CM, Griffin BT. Biopharmaceutical challenges associated with drugs with low aqueous solubility- -the potential impact of lipid-based formulations. Adv Drug Deliv Rev. 2008;60(6):617\u201324.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"3495_CR40","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3109\/1061186X.2010.525652","volume":"18","author":"DB Warren","year":"2010","unstructured":"Warren DB, Benameur H, Porter CJ, Pouton CW. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility. J Drug Target. 2010;18(10):704\u201331.","journal-title":"J Drug Target"},{"key":"3495_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejpb.2018.05.032","volume":"129","author":"F Zahir-Jouzdani","year":"2018","unstructured":"Zahir-Jouzdani F, Lupo N, Hermann M, Pr\u00fcfert F, Atyabi F, Schn\u00fcrch AB. Glyceryl ester surfactants: promising excipients to enhance the cell permeating properties of SEDDS. Eur J Pharm Biopharm. 2018;129:154\u201361.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3495_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0169-409X(00)00103-4","volume":"45","author":"MJ Lawrence","year":"2000","unstructured":"Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45(1):89\u2013121.","journal-title":"Adv Drug Deliv Rev"},{"key":"3495_CR43","doi-asserted-by":"publisher","DOI":"10.1201\/9781420089608","volume-title":"Microemulsions: properties and applications","author":"M Fanun","year":"2008","unstructured":"Fanun M. Microemulsions: properties and applications. CRC press; 2008."},{"key":"3495_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/9781118228920","volume-title":"Surfactants and interfacial phenomena","author":"MJ Rosen","year":"2012","unstructured":"Rosen MJ, Kunjappu JT. Surfactants and interfacial phenomena. John Wiley & Sons; 2012."},{"issue":"1\u20133","key":"3495_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0169-409X(00)00130-7","volume":"46","author":"D H\u00f6rter","year":"2001","unstructured":"H\u00f6rter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 2001;46(1\u20133):75\u201387.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3-4","key":"3495_CR46","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0361-9230(91)90145-A","volume":"27","author":"P Tso","year":"1991","unstructured":"Tso P, Fujimoto K. The absorption and transport of lipids by the small intestine. Brain Res Bull. 1991;27(3\u20134):477\u201382.","journal-title":"Brain Res Bull"},{"key":"3495_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.105027","volume":"138","author":"MH Patel","year":"2019","unstructured":"Patel MH, Sawant KK. Self microemulsifying drug delivery system of lurasidone hydrochloride for enhanced oral bioavailability by lymphatic targeting: in vitro, Caco-2 cell line and in vivo evaluation. Eur J Pharm Sci. 2019;138:105027.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3495_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s11274-015-1965-4","volume":"32","author":"A Hussain","year":"2016","unstructured":"Hussain A, Singh SK. Evidences for anti-mycobacterium activities of lipids and surfactants. World J Microbiol Biotechnol. 2016;32(1):7.","journal-title":"World J Microbiol Biotechnol"},{"issue":"5","key":"3495_CR49","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/jps.2600770512","volume":"77","author":"AT Serajuddin","year":"1988","unstructured":"Serajuddin AT, Sheen PC, Mufson D, Bernstein DF, Augustine MA. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. J Pharm Sci. 1988;77(5):414\u20137.","journal-title":"J Pharm Sci"},{"key":"3495_CR50","first-page":"49","volume":"87","author":"BJ Aungst","year":"1994","unstructured":"Aungst BJ, Nguyen N, Rogers NJ, Rowe S, Hussain M, Shum L, et al. Improved oral bioavailability of an HIV protease inhibitor using Gelucire 44\/14 and Labrasol vehicles. BT Gattefosse. 1994;87:49\u201354.","journal-title":"BT Gattefosse"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03495-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03495-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03495-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:50:08Z","timestamp":1788976208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03495-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3495"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03495-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"279"}}